465 related articles for article (PubMed ID: 25658439)
1. Bullous pemphigoid-like eruption subsequent to scabies: bullous scabies or bullous pemphigoid?
Huang MX; Li ZS; Luo DQ; Lin Q
G Ital Dermatol Venereol; 2015 Jun; 150(3):337-9. PubMed ID: 25658439
[No Abstract] [Full Text] [Related]
2. Bullous eruption associated with scabies: evidence for scabetic induction of true bullous pemphigoid.
Konishi N; Suzuki K; Tokura Y; Hashimoto T; Takigawa M
Acta Derm Venereol; 2000; 80(4):281-3. PubMed ID: 11028862
[TBL] [Abstract][Full Text] [Related]
3. Concurrence of autoantibodies to bullous pemphigoid antigens and desmoglein 3: analysis of pathogenic and nonpathogenic antibodies.
Ono S; Tanioka M; Tanizaki H; Fujisawa A; Koga H; Hashimoto T; Kamiya K; Aoyama Y; Iwatsuki K; Miyachi Y
Br J Dermatol; 2013 Jun; 168(6):1357-60. PubMed ID: 23738642
[No Abstract] [Full Text] [Related]
4. Case of pemphigoid vegetans positive with both BP180 and BP230 in enzyme-linked immunosorbent assays.
Nagamoto E; Fujisawa A; Jinnin M; Koga H; Ishii N; Hashimoto T; Yoshino Y
J Dermatol; 2014 Jul; 41(7):667-8. PubMed ID: 24985550
[No Abstract] [Full Text] [Related]
5. [Auto-immune bullous diseases autoantibodies (pemphigus, bullous pemphigoid): what the dermatologist must know].
Ingen-Housz-Oro S; Hüe S; Grootenboer-Mignot S; André C
Ann Dermatol Venereol; 2013; 140(8-9):563-70. PubMed ID: 24034645
[No Abstract] [Full Text] [Related]
6. [Bullous pemphigoid: diagnosis and therapy].
Kneisel A; Hertl M
Wien Med Wochenschr; 2014 Sep; 164(17-18):363-71. PubMed ID: 25077677
[TBL] [Abstract][Full Text] [Related]
7. Detection of anti-BP180NC16a and anti-BP230 autoantibodies in blister fluid of patients with bullous pemphigoid: the first survey in Greece.
Patsatsi A; Vyzantiadis TA; Devliotou-Panagiotidou D; Chrysomallis F; Sotiriadis D
Clin Exp Dermatol; 2008 Mar; 33(2):183-5. PubMed ID: 18093242
[TBL] [Abstract][Full Text] [Related]
8. Enzyme-linked immunosorbent assay for the combination of bullous pemphigoid antigens 1 and 2 in the diagnosis of bullous pemphigoid.
Roussel A; Benichou J; Randriamanantany ZA; Gilbert D; Drenovska K; Houivet E; Tron F; Joly P
Arch Dermatol; 2011 Mar; 147(3):293-8. PubMed ID: 21422336
[TBL] [Abstract][Full Text] [Related]
9. ELISA instead of indirect IF in patients with BP: Comment on "Usefulness of BP230 and BP180-NC16a enzyme-linked immunosorbent assays in the initial diagnosis of bullous pemphigoid".
Chan LS
Arch Dermatol; 2011 Mar; 147(3):291-2. PubMed ID: 21422335
[No Abstract] [Full Text] [Related]
10. Unusual bullous pemphigoid without infiltration of inflammatory cells in the skin lesions.
Hara H; Makino T; Matsui K; Takegami Y; Koga H; Fukuda S; Ishii N; Hashimoto T; Shimizu T
Eur J Dermatol; 2014; 24(4):488-9. PubMed ID: 25178966
[No Abstract] [Full Text] [Related]
11. Bullous pemphigoid associated with Shy-Drager syndrome.
Okazaki A; Iida T; Muramatsu T; Shirai T; Murata K; Takayanagi T
J Dermatol; 1998 Jul; 25(7):465-8. PubMed ID: 9714981
[TBL] [Abstract][Full Text] [Related]
12. Pemphigoid gestationis with autoantibodies exclusively directed to the 230-kDa bullous pemphigoid antigen (BP230Ag).
Ghohestani R; Nicolas JF; Kanitakis J; Bedane C; Faure M; Claudy A
Br J Dermatol; 1996 Mar; 134(3):603-4. PubMed ID: 8731696
[No Abstract] [Full Text] [Related]
13. Evaluation of a new ELISA assay for detection of BP230 autoantibodies in bullous pemphigoid.
Tampoia M; Lattanzi V; Zucano A; Villalta D; Filotico R; Fontana A; Vena GA; Di Serio F
Ann N Y Acad Sci; 2009 Sep; 1173():15-20. PubMed ID: 19758126
[TBL] [Abstract][Full Text] [Related]
14. An immunogenetic study of bullous pemphigoid with mucosal involvement in two siblings.
Minagawa A; Arakura F; Koga H; Tokuda Y; Koga H; Hashimoto T; Okuyama R
Eur J Dermatol; 2015 Apr; 25(2):186-8. PubMed ID: 25513716
[No Abstract] [Full Text] [Related]
15. IgE autoantibodies in bullous pemphigoid: supporting role, or leading player?
Ujiie H
J Dermatol Sci; 2015 Apr; 78(1):5-10. PubMed ID: 25797172
[TBL] [Abstract][Full Text] [Related]
16. BP180- and BP230-specific IgG autoantibodies in pruritic disorders of the elderly: a preclinical stage of bullous pemphigoid?
Schmidt T; Sitaru C; Amber K; Hertl M
Br J Dermatol; 2014 Aug; 171(2):212-9. PubMed ID: 24601973
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of BP230 and BP180-NC16a enzyme-linked immunosorbent assays in the initial diagnosis of bullous pemphigoid: a retrospective study of 138 patients.
Charneux J; Lorin J; Vitry F; Antonicelli F; Reguiai Z; Barbe C; Tabary T; Grange F; Bernard P
Arch Dermatol; 2011 Mar; 147(3):286-91. PubMed ID: 21422334
[TBL] [Abstract][Full Text] [Related]
18. Blistering insights into the pathogenesis of bullous pemphigoid.
Wong HK; Bechtel MA
Clin Immunol; 2012 Feb; 142(2):101-4. PubMed ID: 22217422
[No Abstract] [Full Text] [Related]
19. Vesicular pemphigoid with circulating autoantibodies against 230-kDa and 180-kDa proteins, and additional autoantibodies against 97-kDa and 45-kDa proteins.
Lai FJ; Sheu HM; Lee JY; Cheng CL; Chen W
Int J Dermatol; 2007 Feb; 46(2):206-9. PubMed ID: 17269979
[TBL] [Abstract][Full Text] [Related]
20. Immunofluorescence-negative bullous pemphigoid sera contain antibodies mostly directed against the 180 kDa bullous pemphigoid antigen (BPAg2).
Ghohestani RF; Claudy A
Br J Dermatol; 1997 Aug; 137(2):306-7. PubMed ID: 9292090
[No Abstract] [Full Text] [Related]
[Next] [New Search]
